γ-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABAB receptors
Authors:
- Felice NavaFNFelice Nava
- Giovanna CartaGCGiovanna Carta
- Marco BortolatoMarco Bortolato
- 1 November 2001
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 430 (2-3) , 261-263
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- γ-Hydroxybutyrate is a weak agonist at recombinant GABAB receptorsNeuropharmacology, 1999
- Involvement of GABAA and GABAB receptors in the mediation of discriminative stimulus effects of γ-hydroxybutyric acidPhysiology & Behavior, 1998
- Gamma‐hydroxybutyrate: an emerging drug of abuse that causes physical dependenceAddiction, 1997
- Oral self-administration of γ-hydroxybutyric acid in the ratEuropean Journal of Pharmacology, 1995
- Gamma-Hydroxybutyric Acid for Treatment of Opiate Withdrawal SyndromeNeuropsychopharmacology, 1993
- Gammahydroxybutyrate and Narcolepsy: A Double-Blind Placebo-Controlled StudySLEEP, 1993
- Gamma‐Hydroxybutyric Acid in the Treatment of Alcohol Dependence: A Double‐Blind StudyAlcohol, Clinical and Experimental Research, 1992
- GAMMA-HYDROXYBUTYRIC ACID FOR TREATMENT OF ALCOHOL WITHDRAWAL SYNDROMEThe Lancet, 1989
- Localization studies of γ-hydroxybutyrate receptors in rat striatum and hippocampusBrain Research Bulletin, 1989
- Mode of action of gamma-butyrolactone on the central cholinergic systemNaunyn-Schmiedeberg's Archives of Pharmacology, 1983